Research hints at underlying cause for Alzheimer’s drug trial failures

A certain form of immunotherapy targeted to Alzheimer’s patients may be ineffective when that patient also has Vascular Cognitive Impairment and Dementia, report scientists. While these drugs showed promise in animal studies, clinical trials have failed to show similar benefits in human patients.